Simon Farrell
Insider CIK 1965585 · TRVI Chief Commercial Officer · SER Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SER Serina Therapeutics, Inc. | A Award deriv | 2026-07-22 | 2026-07-23 | 30,500 | — | $0 | 30,500 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2026-02-19 | 2026-02-20 | 160,000 | — | $0 | 160,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2025-05-31 | 2025-06-03 | 72,000 | — | $0 | 110,400 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2025-03-10 | 2025-03-12 | 31,250 | — | $0 | 18,750 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2025-03-10 | 2025-03-12 | 38,400 | — | $0 | 38,400 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2025-03-10 | 2025-03-12 | 17,500 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2025-03-10 | 2025-03-12 | 63,813 | — | $0 | 11,187 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2025-03-10 | 2025-03-12 | 76,963 | $6.73 | $518.0K | 81,250 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2025-03-10 | 2025-03-12 | 17,500 | $3.21 | $56.2K | 63,150 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2025-03-10 | 2025-03-12 | 63,813 | $3.91 | $249.5K | 126,963 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2025-03-10 | 2025-03-12 | 31,250 | $0.51 | $15.9K | 158,213 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2025-03-10 | 2025-03-12 | 4,350 | $7.15 | $31.1K | 76,900 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2025-02-18 | 2025-02-20 | 225,500 | — | $0 | 225,500 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2024-02-15 | 2024-02-16 | 175,000 | — | $0 | 175,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2023-06-20 | 2023-06-21 | 6,250 | — | $0 | 50,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2023-06-20 | 2023-06-21 | 6,250 | $0.51 | $3.2K | 45,650 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise deriv | 2023-03-07 | 2023-03-08 | 18,750 | — | $0 | 56,250 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | M Exercise | 2023-03-07 | 2023-03-08 | 18,750 | $0.51 | $9.6K | 39,400 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | A Award deriv | 2023-02-16 | 2023-02-16 | 100,000 | — | $0 | 100,000 | SEC↗ |